| In millions, except per share items | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues: |
| U.S. Federal Government and agencies | 241.0 | 232.0 | 233.0 | 225.0 | 241.0 | 237.0 | 254.0 | 267.0 |
| Middle East | 15.0 | 15.0 | 14.0 | 13.0 | 13.0 | 11.0 | 16.0 | 12.0 |
| South America | | | 4.0 | 6.0 | | | 6.0 | 4.0 |
| Europe | 10.0 | 17.0 | 26.0 | 18.0 | 21.0 | 15.0 | 17.0 | 25.0 |
| Other | 172.0 | 141.0 | 191.0 | 175.0 | 198.0 | 129.0 | 174.0 | 128.0 |
| Total revenues [+] | 438.0 | 405.0 | 468.0 | 437.0 | 473.0 | 392.0 | 467.0 | 436.0 |
| Net interest income | | 1.0 | 1.0 | 1.0 | | 1.0 | | 2.0 |
| Revenue growth [+] | -7.4% | 3.3% | 0.2% | 0.2% | 7.7% | 2.9% | 13.9% | 5.6% |
| U.S. Federal Government and agencies | 0.0% | -2.1% | -8.3% | -15.7% | | | | |
| Middle East | 15.4% | 36.4% | -12.5% | 8.3% | | | | |
| South America | | | -33.3% | 50.0% | | | | |
| Europe | -52.4% | 13.3% | 52.9% | -28.0% | | | | |
| Other | -50.0% | -40.0% | | 0.0% | | | | |
| Cost of goods sold | 220.0 | 220.0 | 201.0 | 237.0 | 256.0 | 241.0 | 295.0 | 244.0 |
| Gross profit | 218.0 | 185.0 | 267.0 | 200.0 | 217.0 | 151.0 | 172.0 | 192.0 |
| Gross margin | 49.8% | 45.7% | 57.1% | 45.8% | 45.9% | 38.5% | 36.8% | 44.0% |
| Selling, general and administrative [+] | 106.0 | 104.0 | 108.0 | 89.0 | 88.0 | 84.0 | 95.0 | 90.0 |
| General and administrative | | | 108.0 | | | | 95.0 | |
| Equity in earnings | | | | | | | | |
| EBITDA [+] | 112.0 | 81.0 | 159.0 | 111.0 | 129.0 | 67.0 | 77.0 | 102.0 |
| EBITDA growth | -13.2% | 20.9% | 106.5% | 8.8% | -1.5% | -9.5% | -149.7% | -1.0% |
| EBITDA margin | 25.6% | 20.0% | 34.0% | 25.4% | 27.3% | 17.1% | 16.5% | 23.4% |
| Depreciation | 19.0 | 19.0 | 19.0 | 23.0 | 21.0 | 23.0 | 22.0 | 24.0 |
| EBITA | 93.0 | 62.0 | 140.0 | 88.0 | 108.0 | 44.0 | 55.0 | 78.0 |
| EBITA margin | 21.2% | 15.3% | 29.9% | 20.1% | 22.8% | 11.2% | 11.8% | 17.9% |
| Amortization of intangibles | 48.0 | 49.0 | 50.0 | 51.0 | 52.0 | 51.0 | 52.0 | 71.0 |
| EBIT [+] | 45.0 | 13.0 | 90.0 | 37.0 | 56.0 | -7.0 | 3.0 | 7.0 |
| EBIT growth | -19.6% | -285.7% | 2900.0% | 428.6% | 33.3% | -56.3% | -101.2% | -30.0% |
| EBIT margin | 10.3% | 3.2% | 19.2% | 8.5% | 11.8% | -1.8% | 0.6% | 1.6% |
| Non-recurring items [+] | | | | | | | 19.0 | |
| Asset impairment | | | | | | | 19.0 | |
| Interest expense | 76.0 | 23.0 | 24.0 | 25.0 | 24.0 | 78.0 | 42.0 | 36.0 |
| Interest expense | 76.0 | 23.0 | 24.0 | 25.0 | 24.0 | 78.0 | 42.0 | 36.0 |
| Other income (expense), net [+] | 2.0 | 3.0 | 2.0 | 2.0 | 3.0 | 1.0 | 6.0 | 91.0 |
| Other | -2.0 | -3.0 | 14.0 | -2.0 | -3.0 | -1.0 | 202.0 | -91.0 |
| Pre-tax income | -29.0 | -7.0 | 68.0 | 14.0 | 35.0 | -84.0 | -52.0 | 62.0 |
| Income taxes | 1.0 | 0.0 | -3.0 | 0.0 | -10.0 | 0.0 | 0.0 | -22.0 |
| Tax rate | | 0.0% | | 0.0% | | 0.0% | 0.0% | |
| Earnings from continuing ops | -30.0 | -7.0 | 71.0 | 14.0 | 45.0 | -84.0 | -52.0 | 84.0 |
| Earnings from discontinued ops | | | | | | | 12.0 | 1.0 |
| Net income | -30.0 | -7.0 | 71.0 | 14.0 | 45.0 | -84.0 | -40.0 | 85.0 |
| Net margin | -6.8% | -1.7% | 15.2% | 3.2% | 9.5% | -21.4% | -8.6% | 19.5% |
| |
| Basic EPS [+] | ($0.41) | ($0.10) | $1.01 | $0.19 | $0.62 | ($1.30) | ($0.86) | $1.38 |
| Growth | -165.0% | -92.6% | -217.4% | -86.0% | -87.7% | -0.1% | -196.3% | -300.2% |
| Diluted EPS [+] | ($0.41) | ($0.10) | $0.97 | $0.19 | $0.60 | ($1.30) | ($0.86) | $1.32 |
| Growth | -167.3% | -92.6% | -213.2% | -85.9% | -87.8% | -0.1% | -197.3% | -292.6% |
| |
| Growth | | | | | | | -100.0% | -100.0% |
| |
| Shares outstanding (basic) [+] | 74.0 | 73.2 | 70.6 | 72.6 | 72.2 | 64.8 | 60.7 | 61.0 |
| Growth | 2.5% | 13.0% | 16.3% | 19.0% | 19.1% | 7.8% | 1.8% | 2.3% |
| Shares outstanding (diluted) [+] | 74.0 | 73.2 | 73.2 | 74.7 | 74.7 | 64.8 | 60.7 | 63.4 |
| Growth | -0.9% | 13.0% | 20.6% | 17.8% | 20.5% | 7.8% | 0.8% | 6.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |